Benign hepatic tumours

Zeitschrift fur Gastroenterologie

Volumn 41, Issue 2, 2003, Pages 191-200

  Biecker, E ^a,b   Fischer, H P ^a   Strunk, H ^a   Sauerbruch, T ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Angiomyolipoma; Benign haemangioendothelioma; Benign hepatic tumours; Bile duct adenoma; Biliary cystadenoma; Cavernous haemangioma; Focal nodular hyperplasia; Hepatocellular adenoma; Inflammatory pseudotumour; Nodular regenerative hyperplasia

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; STEROID;

ANGIOMYOLIPOMA; BENIGN TUMOR; BILE DUCT TUMOR; BILIARY TRACT TUMOR; CAVERNOUS HEMANGIOMA; CYSTADENOCARCINOMA; CYSTADENOMA; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HEMANGIOENDOTHELIOMA; HUMAN; LIVER ADENOMA; LIVER HEMORRHAGE; LIVER HYPERPLASIA; LIVER RUPTURE; LIVER TUMOR; NODULAR HYPERPLASIA; PORTAL HYPERTENSION; PSEUDOTUMOR; RELAPSING POLYCHONDRITIS; REVIEW;

ADENOMA, LIVER CELL; ADULT; AGED; DIAGNOSTIC IMAGING; FOCAL NODULAR HYPERPLASIA; GRANULOMA, PLASMA CELL; HEMANGIOENDOTHELIOMA; HEMANGIOMA, CAVERNOUS; HUMANS; INFANT; LIVER; LIVER DISEASES; LIVER NEOPLASMS; LIVER REGENERATION; MIDDLE AGED;

EID: 0347296421     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-37316     Document Type: Review

References (138)

1. Ros PR, Li KC. Benign liver tumors. Curr Probl Diagn Radiol 1989; 18: 125-155
2. Ito K, Honjo K, Fujita T et al. Liver neoplasms: diagnostic pitfalls in cross-sectional imaging. Radiographics 1996; 16: 273-293
3. Gedaly R, Pomposelli JJ, Pomfret EA et al. Cavernous hemangioma of the liver: anatomic resection vs. enucleation. Arch Surg 1999; 134: 407-411
4. Belli L, De Carlis L, Beati C et al. Surgical treatment of symptomatic giant hemangiomas of the liver. Surg Gynecol Obstet 1992; 174: 474-478
5. Saegusa T, Ito K, Oba N et al. Enlargement of multiple cavernous hemangioma of the liver in association with pregnancy. Intern Med 1995; 34: 207-211
6. Conter RL, Longmire WP Jr. Recurrent hepatic hemangiomas. Possible association with estrogen therapy. Ann Surg 1988; 207: 115-119
7. Takahashi T, Kuwao S, Katagiri H et al. Multiple liver hemangiomas enlargement during long-term steroid therapy for myasthenia gravis. Dig Dis Sci 1998; 43: 1553-1561
8. Baker ER, Manders E, Whitney CW. Growth of cavernous hemangioma with puberty. Clin Pediatr (Phila) 1985; 24: 596-598
9. Brunt EM. Benign tumors of the liver. Clin Liver Dis 2001; 5: 1-15, v
10. Trotter JF, Everson GT. Benign focal lesions of the liver. Clin Liver Dis 2001; 5: 17-42, v
11. Pol B, Disdier P, Le Treut YP et al. Inflammatory process complicating giant hemangioma of the liver: report of three cases. Liver Transpl Surg 1998; 4: 204-207
12. Hall GW. Kasabach-Merritt syndrome: pathogenesis and management. Br J Haematol 2001: 112: 851-862
13. Hochwald SN, Blumgart LH. Giant hepatic hemangioma with Kasabach-Merritt syndrome: is the appropriate treatment enucleation or liver transplantation? HPB Surg 2000; 11: 413-419
14. Bree RL, Schwab RE, Glazer GM et al. The varied appearances of hepatic cavernous hemangiomas with sonography, computed tomography, magnetic resonance imaging and scintigraphy. Radiographics 1987; 7: 1153-1175
15. Perkins AB, Imam K, Smith WJ et al. Color and power Doppler sonography of liver hemangiomas: a dream unfulfilled? J Clin Ultrasound 2000; 28: 159-165
16. Quinn SF, Benjamin GG. Hepatic cavernous hemangiomas: simple diagnostic sign with dynamic bolus CT. Radiology 1992; 182: 545-548
17. Soyer P, Dufresne AC, Somveille E et al. Differentiation between hepatic cavernous hemangioma and malignant tumor with T2-weighted MRI: comparison of fast spin-echo and breathhold fast spin-echo pulse sequences. Clin Imaging 1998; 22: 200-210
18. Prakash R, Jena A, Behari V et al. Technetium-99m red blood cell scintigraphy in diagnosis of hepatic hemangioma. Clin Nucl Med 1987; 12: 235-237
19. Kinnard MF, Alavi A, Rubin RA et al. Nuclear imaging of solid hepatic masses. Semin Roentgenol 1995; 30: 375-395
20. Tung GA, Cronan JJ. Percutaneous needle biopsy of hepatic cavernous hemangioma. J Clin Gastroenterol 1993; 16: 117-122
21. Nakaizumi A, Iishi H, Yamamoto R et al. Diagnosis of hepatic cavernous hemangioma by fine needle aspiration biopsy under ultrasonic guidance. Gastrointest Radiol 1990; 15: 39-42
22. Farges O, Daradkeh S, Bismuth H. Cavernous hemangiomas of the liver: are there any indications for resection? World J Surg 1995; 19: 19-24
23. Reddy KR, Kligerman S, Levi J et al. Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome. Am Surg 2001; 67: 173-178
24. Hotokezaka M, Kojima M, Nakamura K et al. Traumatic rupture of hepatic hemangioma. J Clin Gastroenterol 1996; 23: 69-71
25. Klompmaker IJ, Sloof MJ, van der Meer J et al. Orthotopic liver transplantation in a patient with a giant cavernous hemangioma of the liver and Kasabach-Merritt syndrome. Transplantation 1989; 48: 149-151
26. Longeville JH, de la Hall P, Dolan P et al. Treatment of a giant haemangioma of the liver with Kasabach-Merritt syndrome by orthotopic liver transplant a case report. HPB Surg 1997; 10: 159-162
27. Hanazaki K, Kajikawa S, Matsushita A et al. Risk factors associated with intra-operative blood loss in hepatectomized patients with giant cavernous hemangioma of the liver. Hepatogastroenterology 1999; 46: 1089-1093
28. Srivastava DN, Gandhi D, Seith A et al. Transcatheter arterial embolization in the treatment of symptomatic cavernous hemangiomas of the liver: a prospective study. Abdom Imaging 2001; 26: 510-514
29. Suzuki H, Nimura Y, Kamiya J et al. Preoperative transcatheter arterial embolization for giant cavernous hemangioma of the liver with consumption coagulopathy. Am J Gastroenterol 1997; 92: 688-691
30. Tsai MK, Lee PH, Tung BS et al. Experiences in surgical management of cavernous hemangioma of the liver. Hepatogastroenterology 1995; 42: 988-992
31. Bioulac-Sage P, Balabaud C, Wanless IR. Diagnosis of focal nodular hyperplasia: not so easy. Am J Surg Pathol 2001; 25: 1322-1325
32. Klatskin G. Hepatic tumors: possible relationship to use of oral contraceptives. Gastroenterology 1977; 73: 386-394
33. Mathieu D, Kobeiter H, Maison P et al. Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology 2000; 118: 560-564
34. Weimann A, Mossinger M, Fronhoff K et al. Pregnancy in women with observed focal nodular hyperplasia of the liver. Lancet 1998; 351: 1251-1252
35. Colle I, de Beeck BO, Hoorens A et al. Multiple focal nodular hyperplasia. J Gastroenterol 1998; 33: 904-908
36. Sadowski DC, Lee SS, Wanless IR et al. Progressive type of focal nodular hyperplasia characterized by multiple tumors and recurrence. Hepatology 1995; 21: 970-975
37. Schild H, Kreitner KF, Thelen M et al. [Focal nodular hyperplasia of the liver in 930 patients]. ROFO Fortschr Geb Rontgenstr Nuklearmed 1987; 147: 612-618
38. Brunt EM, Flye MW. Infarction in focal nodular hyperplasia of the liver. A case report. Am J Clin Pathol 1991; 95: 503-506
39. Fukukura Y, Nakashima O, Kusaba A et al. Angioarchitecture and blood circulation in focal nodular hyperplasia of the liver. J Hepatol 1998; 29: 470-475
40. Fischer HP, Lankes G. Morphologic correlation between liver epithelium and mesenchyme allows insight into histogenesis of focal nodular hyperplasia (FNH) of the liver. Virchows Arch B Cell Pathol Incl Mol Pathol 1991; 60: 373-380
41. Gaffey MJ, Iezzoni JC, Weiss LM. Clonal analysis of focal nodular hyperplasia of the liver. Am J Pathol 1996; 148: 1089-1096
42. Knowles DM, Wolff M. Focal nodular hyperplasia of the liver: a clinicopathologic study and review of the literature. Hum Pathol 1976; 7: 533-545
43. Cherqui D, Rahmouni A, Charlotte F et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 1995; 22: 1674-1681
44. Harvey CJ, Albrecht T. Ultrasound of focal liver lesions. Eur Radiol 2001; 11: 1578-1593
45. Golli M, Mathieu D, Anglade MC et al. Focal nodular hyperplasia of the liver: value of color Doppler US in association with MR imaging. Radiology 1993; 187: 113-117
46. Uggowitzer MM, Kugler C, Mischinger HJ et al. Echo-enhanced Doppler sonography of focal nodular hyperplasia of the liver. J Ultrasound Med 1999; 18: 445-451; quiz 453-454
47. Ruppert-Kohlmayr AJ, Uggowitzer MM, Kugler C et al. Focal nodular hyperplasia and hepatocellular adenoma of the liver: differentiation with multiphasic helical CT. AJR Am J Roentgenol 2001; 176: 1493-1498
48. Kacl GM, Hagspiel KD, Marincek B. Focal nodular hyperplasia of the liver: serial MRI with Gd-DOTA, superparamagnetic iron oxide, and Gd-EOB-DTPA. Abdom Imaging 1997; 22: 264-267
49. Boulahdour H, Cherqui D, Charlotte F et al. The hot spot hepatobiliary scan in focal nodular hyperplasia. J Nucl Med 1993; 34: 2105-2110
50. Foster JH. Benign liver tumours. In: Blumgart LH (Hrsg). Surgery of the liver and biliary tract. New York: Churchill Livingstone 1994; Vol. 2
51. Kerlin P, Davis GL, McGill DB et al. Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastroenterology 1983; 84: 994-1002
52. Rooks JB, Ory HW, Ishak KG et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. Jama 1979; 242: 644-648
53. Nakao A, Sakagami K, Nakata Y et al. Multiple hepatic adenomas caused by long-term administration of androgenic steroids for aplastic anemia in association with familial adenomatous polyposis. J Gastroenterol 2000; 35: 557-562
54. Labrune P, Trioche P, Duvaltier I et al. Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr 1997; 24: 276-279
55. Baum JK, Bookstein JJ, Holtz F et al. Possible association between benign hepatomas and oral contraceptives. Lancet 1973; 2: 926-929
56. Kent DR, Nissen ED, Nissen SE et al. Effect of pregnancy on liver tumor associated with oral contraceptives. Obstet Gynecol 1978; 51: 148-151
57. Scott LD, Katz AR, Duke JH et al. Oral contraceptives, pregnancy, and focal nodular hyperplasia of the liver. Jama 1984; 251: 1461-1463
58. Scott FR, el-Refaie A, More L et al. Hepatocellular carcinoma arising in an adenoma: value of QBend 10 immunostaining in diagnosis of liver cell carcinoma. Histopathology 1996; 28: 472-474
59. Ferrell LD. Hepatocellular carcinoma arising in a focus of multilobular adenoma. A case report. Am J Surg Pathol 1993; 17: 525-529
60. Mays ET, Christopherson W. Hepatic tumors induced by sex steroids. Semin Liver Dis 1984; 4: 147-157
61. Ribeiro A, Burgart LJ, Nagorney DM et al. Management of liver adenomatosis: results with a conservative surgical approach. Liver Transpl Surg 1998; 4: 388-398
62. Golli M, Van Nhieu JT, Mathieu D et al. Hepatocellular adenoma: color Doppler US and pathologic correlations. Radiology 1994; 190: 741-744
63. Grazioli L, Federle MP, Ichikawa T et al. Liver adenomatosis: clinical, histopathologic, and imaging findings in 15 patients. Radiology 2000; 216: 395-402
64. Arrive L, Flejou JF, Vilgrain V et al. Hepatic adenoma: MR findings in 51 pathologically proved lesions. Radiology 1994; 193: 507-512
65. Herman P, Pugliese V, Machado MA et al. Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. World J Surg 2000; 24: 372-376
66. Shortell CK, Schwartz SI. Hepatic adenoma and focal nodular hyperplasia. Surg Gynecol Obstet 1991; 173: 426-431
67. Flowers BF, McBurney RP, Vera SR. Ruptured hepatic adenoma. A spectrum of presentation and treatment. Am Surg 1990; 56: 380-383
68. Belghiti J, Pateron D, Panis Y et al. Resection of presumed benign liver tumours. Br J Surg 1993; 80: 380-383
69. Terkivatan T, de Wilt JH, de Man RA et al. Treatment of ruptured hepatocellular adenoma. Br J Surg 2001; 88: 207-209
70. Ault GT, Wren SM, Ralls PW et al. Selective management of hepatic adenomas. Am Surg 1996; 62: 825-829
71. Stolzel U, Tannapfel A, Wittekind C et al. [Indications for liver biopsy in liver tumors]. Dtsch Med Wochenschr 2000; 125: 1041-1044
72. Tannapfel A, Wittekind C. [Preneoplasia of the liver. Definition-differential diagnosis-clinical consequences]. Pathologe 2001; 22: 399-406
73. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990; 11: 787-797
74. Nakanuma Y. Nodular regenerative hyperplasia of the liver: retrospective survey in autopsy series. J Clin Gastroenterol 1990; 12: 460-465
75. Zhou H, Wolff M, Pauleit D et al. Multiple macroregenerative nodules in liver cirrhosis due to Budd-Chiari syndrome. Case reports and review of the literature. Hepatogastroenterology 2000; 47: 522-527
76. Dumortier J, Boillot O, Chevallier M et al. Familial occurrence of nodular regenerative hyperplasia of the liver: a report on three families. Gut 1999; 45: 289-294
77. Haboubi NY, Smith VJ, Coyne JD et al. Nodular regenerative hyperplasia of the liver in a non-treated patient with mesangiocapillary glomerulonephritis. Histopathology 1991; 18: 367-368
78. Shimamatsu K, Wanless IR. Role of ischemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver. Hepatology 1997; 26: 343-350
79. Washington K, Lane KL, Meyers WC. Nodular regenerative hyperplasia in partial hepatectomy specimens. Am J Surg Pathol 1993; 17: 1151-1158
80. Stromeyer FW, Ishak KG. Nodular transformation (nodular "regenerative" hyperplasia) of the liver. A clinicopathologic study of 30 cases. Hum Pathol 1981; 12: 60-71
81. Nzeako UC, Goodman ZD, Ishak KG. Hepatocellular carcinoma and nodular regenerative hyperplasia: possible pathogenetic relationship. Am J Gastroenterol 1996; 91: 879-884
82. Loinaz C, Colina F, Musella M et al. Orthotopic liver transplantation in 4 patients with portal hypertension and non-cirrhotic nodular liver. Hepatogastroenterology 1998; 45: 1787-1794
83. Dachman AH, Ros PR, Goodman ZD et al. Nodular regenerative hyperplasia of the liver: clinical and radiologic observations. AJR Am J Roentgenol 1987; 148: 717-722
84. Trauner M, Stepan KM, Resch M et al. Diagnostic problems in nodular regenerative hyperplasia (nodular transformation) of the liver. Review of the literature and report of two cases. Z Gastroenterol 1992; 30: 187-194
85. Patriarche C, Pelletier G, Attali P et al. Ultrasonography, angiography, computed tomography and magnetic resonance in nodular regenerative hyperplasia of the liver: report of a pseudo-tumoral case. Radiat Med 1988; 6: 111-114
86. Radomski JS, Chojnacki KA, Moritz MJ et al. Results of liver transplantation for nodular regenerative hyperplasia. Am Surg 2000; 66: 1067-1070
87. Dumortier J, Bizollon T, Scoazec JY et al. Orthotopic liver transplantation for idiopathic portal hypertension: indications and outcome. Scand J Gastroenterol 2001; 36: 417-422
88. Dachman AH, Lichtenstein JE, Friedman AC et al. Infantile hemangioendothelioma of the liver: a radiologic-pathologic-clinical correlation. AJR Am J Roentgenol 1983; 140: 1091-1096
89. Diment J, Yurim O, Pappo O. Infantile Hemangioendothelioma of the Liver in an Adult. Arch Pathol Lab Med 2001; 125: 931-932
90. Selby DM, Stocker JT, Waclawiw MA et al. Infantile hemangioendothelioma of the liver. Hepatology 1994; 20: 39-45
91. Braun P, Ducharme JC, Riopelle JL et al. Hemangiomatosis of the liver in infants. J Pediatr Surg 1975; 10: 121-126
92. Dehner LP, Ishak KG. Vascular tumors of the liver in infants and children. A study of 30 cases and review of the literature. Arch Pathol 1971; 92: 101-111
93. Kaniklides C, Dimopoulos PA, Bajic D. Infantile hemangioendothelioma. A case report. Acta Radiol 2000; 41: 161-164
94. Keslar PJ, Buck JL, Selby DM. From the archives of the AFIP. Infantile hemangioendothelioma of the liver revisited. Radiographics 1993; 13: 657-670
95. Sato M, Ishida H, Konno K et al. Liver tumors in children and young patients: sonographic and color Doppler findings. Abdom Imaging 2000; 25: 596-601
96. Ezekowitz RA, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 1992; 326: 1456-1463
97. Burrows PE, Rosenberg HC, Chuang HS. Diffuse hepatic hemangiomas: percutaneous transcatheter embolization with detachable silicone balloons. Radiology 1985; 156: 85-88
98. McHugh K, Burrows PE. Infantile hepatic hemangioendotheliomas: significance of portal venous and systemic collateral arterial supply. J Vasc Interv Radiol 1992; 3: 337-344
99. Hurvitz SA, Hurvitz CH, Sloninsky L et al. Successful treatment with cyclophosphamide of life-threatening diffuse hemangiomatosis involving the liver. J Pediatr Hematol Oncol 2000; 22: 527-532
100. Enjolras O, Riche MC, Merland JJ et al. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 1990; 85: 491-498
101. Daller JA, Bueno J, Gutierrez J et al. Hepatic hemangioendothelioma: clinical experience and management strategy. J Pediatr Surg 1999; 34: 98-105; discussion 105-106
102. Corbella F, Arico M, Podesta AF et al. Infantile hepatic hemangioendothelioma treated by radiotherapy. Pediatr Radiol 1983; 13: 297-300
103. Nonomura A, Minato H, Kurumaya H. Angiomyolipoma predominantly composed of smooth muscle cells: problems in histological diagnosis. Histopathology 1998; 33: 20-27
104. Goodman ZD, Ishak KG. Angiomyolipomas of the liver. Am J Surg Pathol 1984; 8: 745-750
105. Nonomura A, Mizukami Y, Kadoya M. Angiomyolipoma of the liver: a collective review. J Gastroenterol 1994; 29: 95-105
106. Barnard M, Lajoie G. Angiomyolipoma: immunohistochemical and ultrastructural study of 14 cases. Ultrastruct Pathol 2001; 25: 21-29
107. Ahmadi T, Itai Y, Takahashi M et al. Angiomyolipoma of the liver: significance of CT and MR dynamic study. Abdom Imaging 1998; 23: 520-526
108. Yeh CN, Chen MF, Hung CF et al. Angiomyolipoma of the liver. J Surg Oncol 2001; 77: 195-200
109. Coffin CM, Humphrey PA, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor: a clinical and pathological survey. Semin Diagn Pathol 1998; 15: 85-101
110. Gollapudi P, Chejfec G, Zarling EJ. Spontaneous regression of hepatic pseudotumor. Am J Gastroenterol 1992; 87: 214-217
111. Cheuk W, Chan JK, Shek TW et al. Inflammatory pseudotumor-like follicular dendritic cell tumor: a distinctive low-grade malignant intra-abdominal neoplasm with consistent Epstein-Barr virus association. Am J Surg Pathol 2001; 25: 721-731
112. Shek TW, Liu CL, Peh WC et al. Intra-abdominal follicular dendritic cell tumour: a rare tumour in need of recognition. Histopathology 1998; 33: 465-470
113. Selves J, Meggetto F, Brousset P et al. Inflammatory pseudotumor of the liver. Evidence for follicular dendritic reticulum cell proliferation associated with clonal Epstein-Barr virus. Am J Surg Pathol 1996; 20: 747-753
114. Zavaglia C, Barberis M, Gelosa F et al. Inflammatory pseudotumour of the liver with malignant transformation. Report of two cases. Ital J Gastroenterol 1996; 28: 152-159
115. Shek TW, Ho FC, Ng IO et al. Follicular dendritic cell tumor of the liver. Evidence for an Epstein-Barr virus-related clonal proliferation of follicular dendritic cells. Am J Surg Pathol 1996; 20: 313-324
116. Shek TW, Ng IO, Chan KW. Inflammatory pseudotumor of the liver. Report of four cases and review of the literature. Am J Surg Pathol 1993; 17: 231-238
117. Flisak ME, Budris DM, Olson MC et al. Inflammatory pseudotumor of the liver: appearance on MRI. Clin Imaging 1994; 18: 1-3
118. Ishida H, Tatsuta M, Furukawa H et al. Multiple inflammatory pseudotumors mimicking liver metastasis from colon cancer: report of a case. Surg Today 2000; 30: 530-533
119. Noi I, Loberant N, Cohen I. Inflammatory pseudotumor of the liver. Clin Imaging 1994; 18: 283-285
120. Jais P, Berger JF, Vissuzaine C et al. Regression of inflammatory pseudotumor of the liver under conservative therapy. Dig Dis Sci 1995; 40: 752-756
121. Li GH, Li JQ, Lin YZ. Inflammatory pseudotumor of the liver. J Surg Oncol 1989; 42: 244-248
122. Mangiante GL, Colombari R, Portuese A et al. Inflammatory pseudotumor of the liver: case report and review of the literature. G Chir 1997; 18: 417-420
123. Karhunen PJ. Benign hepatic tumours and tumour like conditions in men. J Clin Pathol 1986; 39: 183-188
124. Bhathal PS, Hughes NR, Goodman ZD. The so-called bile duct adenoma is a peribiliary gland hamartoma. Am J Surg Pathol 1996; 20: 858-864
125. Govindarajan S, Peters RL. The bile duct adenoma. A lesion distinct from Meyenburg complex. Arch Pathol Lab Med 1984; 108: 922-924
126. Allaire GS, Rabin L, Ishak KG et al. Bile duct adenoma. A study of 152 cases. Am J Surg Pathol 1988; 12: 708-715
127. Colombari R, Tsui WM. Biliary tumors of the liver. Semin Liver Dis 1995; 15: 402-413
128. Tajima T, Honda H, Kuroiwa T et al. Radiologic features of intrahepatic bile duct adenoma: a look at the surface of the liver. J Comput Assist Tomogr 1999; 23: 690-695
129. Devaney K, Goodman ZD, Ishak KG. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol 1994; 18: 1078-1091
130. Wheeler DA, Edmondson HA. Cystadenoma with mesenchymal stroma (CMS) in the liver and bile ducts. A clinicopathologic study of 17 cases, 4 with malignant change. Cancer 1985; 56: 1434-1445
131. Subramony C, Herrera GA, Turbat-Herrera EA. Hepatobiliary cystadenoma. A study of five cases with reference to histogenesis. Arch Pathol Lab Med 1993; 117: 1036-1042
132. Lewis WD, Jenkins RL, Rossi RL et al. Surgical treatment of biliary cystadenoma. A report of 15 cases. Arch Surg 1988; 123: 563-568
133. Thomas JA, Scriven MW, Puntis MC et al. Elevated serum CA 19-9 levels in hepatobiliary cystadenoma with mesenchymal stroma. Two case reports with immunohistochemical confirmation. Cancer 1992; 70: 1841-1846
134. Choi BI, Lim JH, Han MC et al. Biliary cystadenoma and cystadenocarcinoma: CT and sonographic findings. Radiology 1989; 171: 57-61
135. Jenkins RL, Johnson LB, Lewis WD. Surgical approach to benign liver tumors. Semin Liver Dis 1994; 14: 178-189
136. Thommesen N. Biliary hamartomas (von Meyenburg complexes) in liver needle biopsies. Acta Pathol Microbiol Scand [A] 1978; 86: 93-99
137. Ohta W, Ushio H. Histological reconstruction of a Von Meyenburg's complex on the liver surface. Endoscopy 1984; 16: 71-74
138. Ramos A, Torres VE, Holley KE et al. The liver in autosomal dominant polycystic kidney disease. Implications for pathogenesis. Arch Pathol Lab Med 1990; 114: 180-184